Collaboratively close the eumycetoma knowledge gaps to improve the quality of life for mycetoma patients
As already mentioned in our previous report from 2022, the eumycetoma working group is now fully integrated into the global mycetoma working group and almost all the activities are done jointly. We have restarted our online working group meetings and the attendance of these meetings varies between 30 and 60 group members. We also have started joint initiatives such as the global epidemiological survey which is led by the CDC, WHO and DNDi and in which most of our group members participate. Also the Mycetoma Open Source drugs discovery project MycetOS is promoted as all members can participate in that with the aim to develop novel drugs for eumycetoma. Last year eumycetoma causative agents were also listed as high priority pathogens on the fungal pathogen priority list of the WHO and for that a review was written. Due to the many initiatives currently ongoing in the eumycetoma working group we have requested a session at the 22nd ISHAM conference in Iguaçu Falls in Brazil and we hope that the organizing committee will be able to grant us this. This will be very helpful in attracting new members from Latin America as currently most of our members originate from the USA, Europe, Africa and Asia but not many are from Latin America.
Working group meeting during 22nd ISHAM in Iguaçu Falls, Brazil.
Four online mycetoma meetings per year. They are scheduled 3 months apart.
None.